Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Stephan Stilgenbauer Letterio S. Politi Christopher P Fox Stefan W. Krause Roberta Rudà Franco Cavalli Kim Linton Emanuele Zucca |
| Publication date | April 6, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |